The DOI matches its Crossref record; 10 of the 15 references it cites were found in a registry or an index.
Clinical Practice Guidelines for the management of Depression
Open accessAbstract
Participants of expert group on CPG for Depression Gautam Saha, I.D Gupta, Navendu Gaur, Tushar Jagawat, Anita Gautam, T. S Sathyanarayana Rao INTRODUCTION Depression is a common disorder, which often leads to poor quality of life and impaired role functioning. It is known to be a major contributor to the global burden of diseases and according to World Health Organization (WHO), depression is the fourth leading cause of disability worldwide and it is projected that by 2020, it will be the second most common leading cause of disability. Depression is also associated with high rates of suicidal behaviour and mortality. When depression occurs in the context of medical morbidity, it is associated with increased health care cost, longer duration of hospitalization, poor cooperation in treatment, poor treatment compliance and high rates of morbidity. Depression is also known to be associated with difficulties in role transitions (e.g., low education, high teen child-bearing, marital disruption, unstable employment) and poor role functioning (e.g., low marital quality, low work performance, low earnings). It is also reported to be a risk factor for the onset and persistence of a wide range of secondary disorders. Available data also suggests that between one-third and one-half of patients also experience recurrence of depressive episodes. ASSESSMENT AND EVALUATION (table-1)Table 1: Components of assessment and evaluationManagement of depression involves comprehensive assessment and proper establishment of diagnosis. The assessment must be based on detailed history, physical examination and mental state examinations. History must be obtained from all sources, especially the family. The diagnosis must be recorded as per the current diagnostic criteria. Depression often presents with a combination of symptoms of depressed mood, loss of interest or pleasure, decreased energy and fatigue, reduced concentration and attention, reduced self-esteem and self-confidence, ideas of guilt and unworthiness, bleak and pessimistic views of the future, ideas or acts of self-harm or suicide, disturbed sleep and diminished appetite. Depending on the severity of depression some of these symptoms may be more marked and develop characteristic features that are widely regarded as having special clinical significance. These symptoms are known as somatic symptoms of depression and include symptoms of loss of interest or pleasure in activities that are normally enjoyable, lack of emotional reactivity to normally pleasurable surroundings and events, waking up in the morning 2 hours or more before the usual time, depression worse in the morning, objective evidence of definite psychomotor retardation or agitation (remarked on or reported by other people), marked loss of appetite, weight loss (often defined as 5% or more of body weight in the past month) and marked loss of libido. It is important to note that for the diagnosis of depressive disorder these symptoms need to be present for at least 2 weeks and need to be associated with psychosocial dysfunction. Some of the patients with depression may present with predominant complaints of aches, pains and fatigue and they may not report sadness of mood on their own. A careful evaluation of these patients often reveals the underlying features of depression. However, it is important to note that many patients with depression will also have associated anxiety symptoms. With increasing severity of depression patients may report psychotic symptoms and may also present with catatonic features. Thorough assessment also ought to focus on evaluation for comorbid substance abuse/dependence. Careful history of substance intake need to be taken to evaluate the relationship of depression with substance intoxication, withdrawal and abstinence. Whenever required appropriate tests like, urine or blood screens (with prior consent) may be used to confirm the existence of comorbid substance abuse/dependence. Many physical illnesses are known to have high rates of depression. In some situations the physical illnesses have causative role in development of depression, whereas in other situations the relationship/co-occurrence is due to common etiology. Some of the physical illnesses commonly associated with depression are listed in Table-2. When depression occurs in relation to physical illness attempt may be made to clearly delineate the symptoms of depression and physical illness. Further, while making the diagnosis, it maybe clearly mentioned as to which diagnostic approach [i.e., inclusive approach (symptoms are counted whether or not they might be attributable to physical illness), substitute approach (nonsomatic symptoms are substituted with somatic symptoms), exclusive approach (somatic symptoms are deleted from the diagnostic criteria) or best estimate approach] was followed. Further, while reviewing the treatment history of medical illnesses, medication induced depression must be kept in mind, as many medic
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment-resistant depression, mania, and schizophrenia, including clozapine-resistant schizophrenia, are well-recognized indications,[1-6] with evidence from comparative trials (comparison across types of ECT or with waitlisted patients).”
From Clinical Practice Guidelines for the Use of Electroconvulsive Therapy (2023) · cites this paper as [1]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Kennedy, S. H., Lam, R. W. M., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 529
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431
Australian and New Zealand Clinical Practice Guidelines for the Treatment of Depression
Ellis, P., & Australian, R. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01377.x · Cited by 231
Parikh, S. V., Segal, Z. V., Grigoriadis, S., Ravindran, A. V., Kennedy, S. H., Lam, R. W., & Patten, S. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.042 · Cited by 183
An overview of Indian research in depression
Grover, S., Dutt, A., & Avasthi, A. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.69231 · Cited by 177
Self-citationRavindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L. N., Yatham, L. N., Kennedy, S. H., Lam, R. W. M., et al. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.16106 · Cited by 67
Research on antidepressants in India
Avasthi, A., Grover, S., & Aggarwal, M. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.69263 · Cited by 18
Self-citationA systematic review and meta-analysis of trials of treatment of depression from India
Grover, S., & Sarkar, S. (2014) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.124711 · Cited by 14
Self-citation
Flagged first, then by citations
5 of the 15 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- American Psychiatry Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition, 2010; pp -152.
Cited by
Sorted by citations
Items 201–232 of 232
Carneiro, A. M., Silva, S. L. T., Fernandes, F. D. S., Barretto, J. R., de Brito, T. R., Moreno, L. H., Pimentel, F. C., Jorge, B., dos Santos, L. A., Ramos, M. R. F., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329006
“In the context of treatment, psychosocial treatments provide benefits and are indicated as a standard treatment [2]; however, many patients face difficulties adhering to recommendations [3].”
Antidepressants and old age: the risks of pharmacotherapy
Kukushkin, G., Yurov, D. E., Kalinina, E., Burenkova, E. E., & Devushkin, D. A. (2025) · Russian Medicine · doi:10.17816/medjrf641965
Chuang, H.-M., Meng, L., Lin, C.-W., Chen, W.-W., Chen, Y.-Y., Shang, C.-Y., Chen, L.-K., & Hsiao, F.-Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.05.032
A case report on the safety and efficacy of aripiprazole for depression in Brugada syndrome
Fahmy, M., Bessada, Y., Ramsey, C., & Zigun, J. R. (2025) · Mental Health Clinician · doi:10.9740/mhc.2025.04.062
Júnior, J. I. R. N., Aires, R., Cutrim, T. A. D. S., Vasquez, E. C., Pereira, T. D. M. C., & Campagnaro, B. P. (2025) · Pharmacological Reports · doi:10.1007/s43440-024-00690-6
“MDD is characterized by persistent sadness and/ or loss of pleasure for a minimum of two weeks, accompanied by at least three of the following symptoms: changes in appetite, cognitive impairments, sleep disturbances, feelings of worthlessness, and thoughts of death or suicide [2 ].”
InfluentialDoes age of ADHD medication initiation predict long-term risk of anxiety? A scoping review
Fletcher, M., Ledbetter, L., Alonso, P., Ansah, O. O., Short, O., & Reuter‐Rice, K. (2025) · PLOS mental health. · doi:10.1371/journal.pmen.0000230
Methylphenidate augmentation for electroconvulsive therapy-resistant major depressive disorder
Tholasappa, V., Yedavally, N. A., Lairenlakpam, B., Motwani, L., Dangaich, R., & Arumugham, S. S. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104372
Indian Essential Medicine List for mental disorders: Time to revisit
Goel, D., & Gupta, A. (2025) · Annals of Medical Science & Research · doi:10.4103/amsr.amsr_40_24
Alkaf, F. H. (2024) · PROSIDING SEMINAR NASIONAL PENDIDIKAN, BAHASA, SASTRA, SENI, DAN BUDAYA · doi:10.55606/mateandrau.v3i2.2875
REVOLUTIONIZING DEPRESSION TREATMENT: A PARADIGM SHIFT OF KETAMINE THERAPY – A SYSTEMATIC REVIEW
Kaushal, Y., Goyal, P., & Sehgal, A. (2024) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2024v17i8.51360
Bogowicz, P., Mehta, A., Choudhary, S., Brhlíková, P., Roderick, P., McGettigan, P., Farooqui, H. H., Sharma, A., & Pollock, A. M. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2372089
Characteristics of depression treatment in men with testosterone deficiency
Osadshiy, Y. Y., & Soldatkina, S. V. (2024) · Neurology Bulletin · doi:10.17816/nb628936
Abhishree, B. S., Bhat, S., Muraraiah, S., & Rajarathna, K. (2024) · Telangana Journal of Psychiatry · doi:10.4103/tjp.tjp_23_24
Thasni, M., Jithesh, M., & Parvatheedevy, M. P. (2024) · Ancient Science of Life · doi:10.4103/asl.asl_130_22
Yovanda, R., Murni, A., & Satuti, W. D. (2024) · Bioscientia Medicina : Journal of Biomedicine and Translational Research · doi:10.37275/bsm.v8i8.1051
Natural Substances in the Adjuvant Therapy of Depression
Lucius, K. (2024) · Integrative and Complementary Therapies · doi:10.1089/ict.2024.27201.kl
Intravenous Ketamine for Suicidal Behavior in Severe Depression with Psychotic Features
Kumar, T. P., Bolla, D., Donthu, R., & Pathak, A. (2024) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_212_23
A Case Report of a Reversible Movement Disorder in an Elderly Male with Late-onset Psychosis
Bhat, A., Dakshikar, S., Meshram, S., & Fatima, J. (2024) · Telangana Journal of IMA · doi:10.4103/tjima.tjima_2_24
Fan, Q., Guo, L.-H., Feng, Y.-X., Kuang, H.-J., Xu, Y., Tang, H., Zaslawski, C., & Zhao, H. (2023) · Guidelines and Standards of Chinese Medicine · doi:10.1097/gscm.0000000000000001
Kumari, B., Kar, S. K., Singh, A. K., Tripathi, A., & Agarwal, V. (2023) · Indian Journal of Behavioural Sciences · doi:10.55229/ijbs.v26i1.05
Senger, M., DORUCH, P., & Kędziora–Kornatowska, K. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.12.042
“Większość z nich wykazuje się podobną skutecznością, lecz ze względu na najkorzystniejszy profil bezpieczeństwa, terapię najczęściej rozpoczyna się od inhibitorów wychwytu zwrotnego serotoniny [62].”
The Impact of Auricular Acupressure on Depression among Nurses
Kim, E. K., You, J., Ji, S.-J., Choi, S.-H., Jin, B.-M., Lee, C.-A., & Lee, E. J. (2022) · Journal of Korean Academy of Psychiatric and Mental Health Nursing · doi:10.12934/jkpmhn.2022.31.3.365
“환자의 병력, 복용 약물, 사회경제적 지원 상태 등을 고려하여 약물요법, 전기경련요법, 비약물요법을 시도할 수 있다[9].”
Ilham, I., Syuhada, S., & Rukaya, B. E. (2022) · Journal Borneo · doi:10.57174/jborn.v2i2.44
“Skizofrenia atau gangguan mental yang lain sebenarnya dapat dikendalikan ataupun dapat disembuhkan dengan perawatan yang intensif seperti dengan mengkonsumsi obat-obat psikotik berdasarkan rekomendasi dokter.(7) Namun, karena profil efek samping dan keamanan dari obat-obat psikotik masih belum dapat dipastikan.”
BackgroundAmmar, A., & Rusli, M. (2022) · Bali Medical Journal · doi:10.15562/bmj.v11i1.2962
Intervention of Yoga in Stress, Anxiety and Depression
Nanthakumar, C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101619
Jimenez-Badilla, I., & Acuña-Amador, L. (2021) · Psiquiatría Biológica · doi:10.1016/j.psiq.2021.100315
Застрожин, М. С., Гришина, Е. А., Рыжикова, К. А., Скрябин, В. Ю., Копоров, С. Г., Брюн, Е., & Сычёв, Д. А. (2021) · doi:10.20538/1682-0363-2020-4-73-79
Застрожин, М. С., Гришина, Е. А., Рыжикова, К. А., Скрябин, В. Ю., Копоров, С. Г., Брюн, Е., & Сычев, Д. А. (2020) · Психиатрия, психотерапия и клиническая психология · doi:10.34883/pi.2020.11.3.013
Part I: Optimizing treatment with antidepressants
Jhawar, A., Parmentier, B. L., & Grady, S. E. (2020) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1213
Zastrozhin, M., Skryabin, V., Ryzhikova, K., & Sychev, D. (2020) · doi:10.33920/med-01-2002-05
Ronzani, T. M., Casela, A. L., Martins, L. F., da Silveira, P. S., & Richter, K. P. (2025) · Cadernos Saúde Coletiva · doi:10.1590/1414-462x202433010461
The role of neuroplasticity in the etiology and treatment of depressive disorders
Konstantinović, I., & Trandafilović, M. (2024) · Acta Facultatis Medicae Naissensis · doi:10.5937/afmnai41-48899
Metadata
- Authors
- Grover, S., Gautam, S., Jain, A., Gautam, M., & Vahia, V.
- Affiliations
- Post Graduate Institute of Medical Education and Research (IN)
- Employees' State Insurance Model Hospital (IN)
- Corresponding author
- Grover, Sandeep
- ORCID
- Grover, Sandeep
- Venue
- Indian Journal of Psychiatry
- Published
- 2017
- Volume
- 59
- Issue
- 5
- Pages
- 34
- ISSN
- 0019-5545 (ISSN-L)
- PMC
- PMC5310101
- OpenAlex
- W2568301711
- Cited by
- 269
- References
- 15
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 52 · 2023: 29 · 2022: 29 · 2021: 29 · 2020: 29 · 2019: 12 · 2018: 10 · 2017: 3
- FWCI
- 10.31
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Indian Journal of Psychiatry (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- depression, depression treatment, depression assessment, diagnostic criteria, somatic symptoms of depression, antidepressant treatment, antidepressant side effects, antidepressant discontinuation, antidepressant switching, antidepressant augmentation, antidepressant combination therapy, depression recurrence, relapse prevention, psychotherapy, suicide risk, comorbid depression, quality of life, role functioning, global burden of disease, health care costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review